The results showed that PTK2 mRNA expression was upregulated (90/102, 88.24%) (Fig. 4G), whereas pre-mRNA expression was downregulated (95/102, 93.14%) (Fig. 4I) in BC tissues compared with that in the adjacent normal tissues. This evidence concerns the gene PTK2 and breast cancer.